ASCO GU Roundup: A Comprehensive Overview

News
Article

Research across kidney, bladder, and prostate cancers was showcased January 25-27 in San Francisco, California.

The Genitourinary Cancers Symposium took place Thursday, January 25, 2024, to Saturday, January 27, 2024, in San Francisco, California. Posters and presentations revealed the latest updates across kidney, bladder, and prostate cancer research. 

Immunotherapy took center stage, with findings from the phase 3 AMBASSADOR Alliance A031501 (NCT03244384) and KEYNOTE-564 (NCT03142334) trials. Findings from a phase 2 trial (NCT03012321) of olaparib (Lynparza) plus abiraterone (Zytiga) and prednisone in metastatic castration-resistant prostate cancer (mCRPC) with BRCA1/2 or ATM alterations were also highly anticipated.

Here are some of the highlights from the 3-day event.

Kidney Cancer

Kidneys, adrenal glands, genitourinary system, body scan, joint, medical screen 3D render, human anatomy, computer anatomy, body skeleton, X-ray scan: © Leo Viktorov - stock.adobe.com

Kidneys, adrenal glands, genitourinary system: © Leo Viktorov - stock.adobe.com

Bladder Cancer : © SciePro - stock.adobe.com

Bladder Cancer : © SciePro - stock.adobe.com

Bladder Cancer

Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland: © Dr_Microbe - stock.adobe.com

Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland: © Dr_Microbe - stock.adobe.com

Prostate Cancer

Recent Videos
Related Content